Packaging is a major part of the pharmaceutical market as it aids in keeping the drugs (chemicals, APIs, and finished dosage forms) safe from damage and contamination during storage and shipping. Packaging systems used for pharmaceutical products include, blister pack, pill box, and fiber drums (bulk drugs) for solid dosage forms; glass bottles, vials, and ampoules for liquid dosage forms; and tubes for semi-solid dosage forms.
Statistics:
Latin America Pharmaceutical Products CMO Market is estimated to account for US$ 40,070.3 Mn in terms of value by the end of 2027.
Latin America Pharmaceutical Products CMO Market: Drivers
Increasing expansion of international pharmaceutical companies in Latin America is expected to propel growth of Latin America Pharmaceutical Products CMO Market over the forecast period. For instance, in April 2020, m8 Pharmaceuticals, a pharmaceutical company based in the U.S., and Gennisium Pharma, based in France, entered into an exclusive agreement under which m8 Pharmaceuticals has the exclusive rights to register and commercialize a more suitable formulation of an already existing orphan drug for apnea in Mexico and Brazil.
To learn more about this report, request a sample copy*
* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy of this report@ https://www.coherentmarketinsights.com/insight/request-sample/3933
Latin America Pharmaceutical Products CMO Market: Opportunities
Expansion of pharmaceutical packaging sector is expected to offer lucrative growth opportunities for players in the market. For instance, in April 2020, Klöckner Pentaplast, a provider of pharmaceutical packaging films, completed expansion at its Cotia facility in Brazil.
Latin America Pharmaceutical Products CMO Market: Restraints
Low healthcare expenditure is expected to hinder growth of Latin America Pharmaceutical Products CMO Market. For instance, according to the survey by Brazil’s Federal Council of Medicine in 2018, per capita public spending on health care in Brazil did not increase above the country’s official inflation—which rose 80% from 2008 to 2017.
Special Requirements?
We value your investment and offer customization as per your requirements.
Share your precise requirements @ https://www.coherentmarketinsights.com/insight/request-customization/3933
Key Takeaways:
Latin America Pharmaceutical Products CMO Market was valued at US$ 13,266.5 Mn in 2019 and is forecast to reach a value of US$ 40,070.3 Mn by 2027 at a CAGR of 14.8% between 2020 and 2027. Increasing expansion of international pharmaceutical companies in Latin America is expected to propel growth of Latin America Pharmaceutical Products CMO Market over the forecast period.
API and Ingredients segment held dominant position in Latin America Pharmaceutical Products CMO Market in 2019, accounting for 60.0% share in terms of value, followed by Finished Dosage Form respectively. Increasing demand for pharmaceutical drugs to treat chronic disorders is expected to assist the growth of the market.
Market Trends
Increasing adoption of telemedicine is expected to aid in growth of the market. For instance, in March 2020, VivaBem, a digital health tech start-up based in Brazil, partnered with Doktor.se, a telemedicine provider based in Sweden, to expand its digital primary care services in Brazil.
The market is witnessing increasing M&A activities. For instance, in October 2019, Knight Therapeutics announced its plans to acquire Biotoscana Investments, a Brazil-based pharmaceutical company for US$ 281 million. In May 2019, Hapvida Participacoes e Investimentos SA acquired Sao Francisco Saude.
Access research reports that are tailored specifically for you and your organization in order to explore practical growth strategies and recommendations
Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/3933
Latin America Pharmaceutical Products CMO Market: Competitive Landscape
Major players operating in Latin America Pharmaceutical Products CMO Market include, BASF SE, Bayer AG, Boehringer Ingelheim GmbH, F. Hoffmann-La Roche Ltd., Merck & Co., Inc., Novartis AG, Pfizer, Inc., Pisa Farmacéutica, Fresenius SE & Co. KGaA, Takeda Pharmaceutical Company Limited, Ferring Pharmaceuticals, Inc., and Landsteiner Scientific.
Latin America Pharmaceutical Products CMO Market: Key Developments
March 2020: Takeda Pharmaceutical Company Limited entered into an agreement to divest a portfolio of select non-core products exclusively in Latin America to Hypera S.A., a pharmaceutical company in Brazil
July 2019: Hapvida Participacoes e Investimentos SA, a healthcare company based in Brazil, launched a share offering to raise around US$ 704 million
Browse Press Release: https://www.coherentmarketinsights.com/press-release/latin-america-pharmaceutical-products-cmo-market-3202
Segmentation
Scope of the report
- Latin America Pharmaceutical Products CMO Market, By Product Type:
- API and Ingredients
- Finished Dosage Form
- Pharmaceutical Packaging
- Latin America Pharmaceutical Products CMO Market, By Country:
- Brazil
- By Product Type:
- API and Ingredients
- Finished Dosage Form
- Pharmaceutical Packaging
- By Product Type:
- Mexico
- By Product Type:
- API and Ingredients
- Finished Dosage Form
- Pharmaceutical Packaging
- By Product Type:
- Argentina
- By Product Type:
- API and Ingredients
- Finished Dosage Form
- Pharmaceutical Packaging
- By Product Type:
- Rest of Latin America
- By Product Type:
- API and Ingredients
- Finished Dosage Form
- Pharmaceutical Packaging
- By Product Type:
- Brazil
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837